Jiangsu Hengrui Medicine Co., Ltd. (SHA:600276)
China · Delayed Price · Currency is CNY 61.69
-1.39 (-2.20%)
Aug 19, 2025, 3:00 PM CST
Jiangsu Hengrui Medicine Market Cap
Jiangsu Hengrui Medicine has a market cap or net worth of 412.02 billion as of August 19, 2025. Its market cap has increased by 56.48% in one year.
Market Cap
412.02B
Enterprise Value
388.49B
Revenue
29.19B
Ranking
n/a
PE Ratio
56.52
Stock Price
61.69
Market Cap Chart
Since October 20, 2000, Jiangsu Hengrui Medicine's market cap has increased from 2.58B to 412.02B, an increase of 15,890.98%. That is a compound annual growth rate of 22.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2025 | 412.02B | 41.17% |
| Dec 31, 2024 | 291.86B | 1.48% |
| Dec 29, 2023 | 287.60B | 17.03% |
| Dec 30, 2022 | 245.74B | -23.94% |
| Dec 31, 2021 | 323.08B | -45.40% |
| Dec 31, 2020 | 591.75B | 53.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| WuXi AppTec | 286.29B |
| Shenzhen Mindray Bio-Medical Electronics | 284.49B |
| Sichuan Biokin Pharmaceutical | 123.82B |
| Aier Eye Hospital Group | 121.31B |
| Zhangzhou Pientzehuang Pharmaceutical., | 121.22B |
| Shanghai United Imaging Healthcare | 104.93B |
| Yunnan Baiyao Group Co.,Ltd | 99.85B |
| Huadong Medicine | 75.26B |